Dr. Brendan Buckley is Chief Medical Officer and Executive Vice President of ICON plc, one of the world’s largest clinical research organizations.
A medical graduate of the National University of Ireland and a doctoral graduate in Biochemistry of Oxford University, he has over 30 years’ experience in clinical research while in academic clinical practice.
He is Honorary Clinical Professor at University College Cork (UCC) and Adjunct Professor at University College Dublin (UCD). Prior to joining ICON, he was Director of the European collaborative Centre for Clinical Trials in Rare Diseases at UCC..
He was a member of the Board of Directors of Ireland’s national health products regulator the Irish Medicines Board (now the HPRA) in 2004-2011 and chaired its statutory Advisory Committee for Human Medicines. He was a member of the EMA Committee for Orphan Medicinal Products (COMP) from 2000-2003 and a member of the EMA Scientific Advisory Committee on Diabetes and Metabolism until 2011.
He was a co-founder of Firecrest Clinical, a company in Limerick focused on improving the performance of clinical trial sites.
He has directed a number of very large outcomes trials in metabolic /cardiovascular disease and chairs the independent data and safety monitoring boards for a number of large clinical development programmes. He is a member of the scientific advisory boards of a number of research charities.